3.0.0 4117 2023-01-11T13:38:23Z 2023-01-11T13:38:23Z House HR 2017-10-25 115 [Congressional Record Volume 163, Number 172 (Wednesday, October 25, 2017)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. DOGGETT:H.R. 4117.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clauses 1, 3 and 18 of theConstitution of the United States of America[Page H8225]]]> hsif00 Energy and Commerce Committee House Standing hsif17 Innovation, Data, and Commerce Subcommittee Referred to 2017-10-27T20:24:32Z Referred to 2017-10-25T14:01:10Z hsju00 Judiciary Committee House Standing Referred to 2017-10-25T14:01:05Z hswm00 Ways and Means Committee House Standing Referred to 2017-10-25T14:01:00Z 2017-10-27 hsif17 Innovation, Data, and Commerce Subcommittee 1 House committee actions Referred to the Subcommittee on Digital Commerce and Consumer Protection. Committee 2017-10-25 Referred to the Committee on Ways and Means, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2017-10-25 Referred to the Committee on Ways and Means, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2017-10-25 Referred to the Committee on Ways and Means, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2017-10-25 Introduced in House IntroReferral Intro-H 9 Library of Congress 2017-10-25 Introduced in House IntroReferral 1000 9 Library of Congress D000399 Rep. Doggett, Lloyd [D-TX-35] LLOYD DOGGETT D TX 35 N C000984 Rep. Cummings, Elijah E. [D-MD-7] ELIJAH CUMMINGS D MD E. 7 2017-10-25 True D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 2017-10-25 True S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 2017-10-25 True P000607 Rep. Pocan, Mark [D-WI-2] Mark Pocan D WI 2 2017-10-25 True C001080 Rep. Chu, Judy [D-CA-27] Judy Chu D CA 27 2017-10-25 True C001084 Rep. Cicilline, David N. [D-RI-1] David Cicilline D RI N. 1 2017-10-25 True C001068 Rep. Cohen, Steve [D-TN-9] Steve Cohen D TN 9 2017-10-25 True C000714 Rep. Conyers, John, Jr. [D-MI-13] JOHN CONYERS D MI 13 2017-10-25 True E000288 Rep. Ellison, Keith [D-MN-5] Keith Ellison D MN 5 2017-10-25 True G000551 Rep. Grijalva, Raúl M. [D-AZ-3] Raúl Grijalva D AZ M. 3 2017-10-25 True K000009 Rep. Kaptur, Marcy [D-OH-9] MARCY KAPTUR D OH 9 2017-10-25 True K000389 Rep. Khanna, Ro [D-CA-17] Ro Khanna D CA 17 2017-10-25 True L000559 Rep. Langevin, James R. [D-RI-2] JAMES LANGEVIN D RI R. 2 2017-10-25 True N000002 Rep. Nadler, Jerrold [D-NY-10] JERROLD NADLER D NY 10 2017-10-25 True N000179 Rep. Napolitano, Grace F. [D-CA-32] GRACE NAPOLITANO D CA F. 32 2017-10-25 True O000170 Rep. O'Rourke, Beto [D-TX-16] Beto O'Rourke D TX 16 2017-10-25 True P000597 Rep. Pingree, Chellie [D-ME-1] Chellie Pingree D ME 1 2017-10-25 True C001066 Rep. Castor, Kathy [D-FL-14] Kathy Castor D FL 14 2017-10-25 True R000606 Rep. Raskin, Jamie [D-MD-8] Jamie Raskin D MD 8 2017-10-25 True V000081 Rep. Velazquez, Nydia M. [D-NY-7] NYDIA VELAZQUEZ D NY M. 7 2017-10-25 True J000298 Rep. Jayapal, Pramila [D-WA-7] Pramila Jayapal D WA 7 2017-11-28 False W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT 0 2017-11-28 False B000574 Rep. Blumenauer, Earl [D-OR-3] EARL BLUMENAUER D OR 3 2018-01-18 False N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] ELEANOR NORTON D DC HOLMES 0 2018-04-11 False C001090 Rep. Cartwright, Matt [D-PA-17] Matt Cartwright D PA 17 2018-06-15 False L000557 Rep. Larson, John B. [D-CT-1] JOHN LARSON D CT B. 1 2018-07-11 False G000553 Rep. Green, Al [D-TX-9] Al Green D TX 9 2018-07-19 False C001061 Rep. Cleaver, Emanuel [D-MO-5] Emanuel Cleaver D MO 5 2018-07-19 False S001170 Rep. Shea-Porter, Carol [D-NH-1] Carol Shea-Porter D NH 1 2018-07-19 False G000581 Rep. Gonzalez, Vicente [D-TX-15] Vicente Gonzalez D TX 15 2018-07-19 False D000623 Rep. DeSaulnier, Mark [D-CA-11] Mark DeSaulnier D CA 11 2018-07-19 False M001160 Rep. Moore, Gwen [D-WI-4] Gwen Moore D WI 4 2018-07-19 False G000535 Rep. Gutierrez, Luis V. [D-IL-4] LUIS GUTIERREZ D IL V. 4 2018-07-19 False T000193 Rep. Thompson, Bennie G. [D-MS-2] BENNIE THOMPSON D MS 2 2018-07-19 False B001270 Rep. Bass, Karen [D-CA-37] Karen Bass D CA 37 2018-07-19 False W000187 Rep. Waters, Maxine [D-CA-43] MAXINE WATERS D CA 43 2018-09-04 False G000574 Rep. Gallego, Ruben [D-AZ-7] Ruben Gallego D AZ 7 2018-11-30 False Health Administrative remedies Business expenses Civil actions and liability Competition and antitrust Federal Trade Commission (FTC) Income tax deductions Intellectual property Judicial review and appeals Marketing and advertising Prescription drugs Research and development Health 00 2017-10-25 Introduced in House 2019-09-05T15:43:27Z Competitive Deals Resulting in Unleashed Generics and Savings Act of 2017 or the Competitive DRUGS Act of 2017

This bill establishes a series of requirements and prohibitions regarding certain patent infringement agreements between brand name and generic drug manufacturers in which the generic drug manufacturer agrees to delay the availability of applicable generic drugs. Among other things, the bill specifies that such agreements constitute an unfair method of competition and are subject to specified civil penalties.

]]> Competitive DRUGS Act of 2017 Display Title Competitive DRUGS Act of 2017 Short Titles as Introduced Competitive DRUGS Act of 2017 Short Titles as Introduced Competitive Deals Resulting in Unleashed Generics and Savings Act of 2017 Official Title as Introduced To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. Introduced in House 2017-10-25T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr4117ih/xml/BILLS-115hr4117ih.xml 2017-10-27 Referred to the Subcommittee on Digital Commerce and Consumer Protection. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.